- Home
- PHAR vs CRON Comparison
PHAR vs CRON Comparison
Compare PHAR & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | CRON |
|---|---|---|
| Founded | 1988 | N/A |
| Country | Netherlands | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PHAR | CRON |
|---|---|---|
| Price | $16.79 | $2.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 34.2K | ★ 1.5M |
| Earning Date | 03-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.00 | ★ 0.09 |
| Revenue | ★ $362,274,000.00 | $132,357,000.00 |
| Revenue This Year | $25.19 | $17.63 |
| Revenue Next Year | $4.47 | $30.76 |
| P/E Ratio | $3,082.88 | ★ $27.30 |
| Revenue Growth | ★ 26.78 | 19.00 |
| 52 Week Low | $7.50 | $1.60 |
| 52 Week High | $21.34 | $3.43 |
Technical Indicators
Market Signals| Indicator | PHAR | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 45.13 |
| Support Level | $16.30 | $2.40 |
| Resistance Level | $18.03 | $2.77 |
| Average True Range (ATR) | 0.73 | 0.10 |
| MACD | -0.35 | -0.01 |
| Stochastic Oscillator | 9.72 | 40.70 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.